Return to Answers From the Lab

Delta Air Lines Partnership

By Melissa Peterson • July 9, 2020

Related Episodes
Lab Outreach Delivers Value, Growth, and Strategic Advantage

By Samantha Rossi • July 9, 2026
Personalized Therapy Growth Driven by Clinical Diagnostics

By Samantha Rossi • June 25, 2026
How Pharmacogenomics Deliver More Precise Cancer Therapy

By Samantha Rossi • June 11, 2026

Melissa Peterson

Related Posts

Using CSF testing to confirm autoimmune GFAP meningoencephalomyelitis featured image
Using CSF testing to confirm autoimmune GFAP meningoencephalomyelitis
July 16, 2026

Learn how our autoimmune/paraneoplastic evaluation for encephalopathy uses CSF testing to confirm an autoimmune GFAP meningoencephalomyelitis diagnosis.
Bile acids malabsorption panel leads to IBS-D diagnosis featured image
Bile acids malabsorption panel leads to IBS-D diagnosis
July 15, 2026

Learn how our bile acids malabsorption panel was used to diagnose IBS-D in a 72-year-old woman.
Optimizing Urine Drug Monitoring in an Evolving Clinical Landscape featured image
Optimizing Urine Drug Monitoring in an Evolving Clinical Landscape
November 11, 2026

Register now –Nov. 11, 2026 Review the evidence supporting modern urine drug monitoring, compare immunoassay, definitive, and hybrid testing strategies, and provide practical guidance for selecting testing based on clinical scenarios